Oral Peptide Therapy Market, Global Outlook and Forecast 2022-2028

April 2022 | 77 pages | ID: O0A62AE33EA9EN
Market Monitor Global

Abstracts

The drugs give through oral.

This report contains market size and forecasts of Oral Peptide Therapy in global, including the following market information:

Global Oral Peptide Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Oral Peptide Therapy Market Sales, 2017-2022, 2023-2028, (Units)

Global top five Oral Peptide Therapy companies in 2021 (%)

The global Oral Peptide Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Linaclotide Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Oral Peptide Therapy include Allergan, Novo Nordisk, Synergy Pharmaceuticals ?Salix?, Novartis and Chiasma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oral Peptide Therapy manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Oral Peptide Therapy Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Oral Peptide Therapy Market Segment Percentages, by Type, 2021 (%)

• Linaclotide
• Insulin
• Plecanatide
• Cyclosporine
• Octreotide

Global Oral Peptide Therapy Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Oral Peptide Therapy Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Retail Pharmacy

Global Oral Peptide Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Oral Peptide Therapy Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Oral Peptide Therapy revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Oral Peptide Therapy revenues share in global market, 2021 (%)

Key companies Oral Peptide Therapy sales in global market, 2017-2022 (Estimated), (Units)

Key companies Oral Peptide Therapy sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Allergan
• Novo Nordisk
• Synergy Pharmaceuticals ?Salix?
• Novartis
• Chiasma

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Oral Peptide Therapy Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Oral Peptide Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ORAL PEPTIDE THERAPY OVERALL MARKET SIZE

2.1 Global Oral Peptide Therapy Market Size: 2021 VS 2028
2.2 Global Oral Peptide Therapy Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Oral Peptide Therapy Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Oral Peptide Therapy Players in Global Market
3.2 Top Global Oral Peptide Therapy Companies Ranked by Revenue
3.3 Global Oral Peptide Therapy Revenue by Companies
3.4 Global Oral Peptide Therapy Sales by Companies
3.5 Global Oral Peptide Therapy Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Oral Peptide Therapy Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Oral Peptide Therapy Product Type
3.8 Tier 1, Tier 2 and Tier 3 Oral Peptide Therapy Players in Global Market
  3.8.1 List of Global Tier 1 Oral Peptide Therapy Companies
  3.8.2 List of Global Tier 2 and Tier 3 Oral Peptide Therapy Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Oral Peptide Therapy Market Size Markets, 2021 & 2028
  4.1.2 Linaclotide
  4.1.3 Insulin
  4.1.4 Plecanatide
  4.1.5 Cyclosporine
  4.1.6 Octreotide
4.2 By Type - Global Oral Peptide Therapy Revenue & Forecasts
  4.2.1 By Type - Global Oral Peptide Therapy Revenue, 2017-2022
  4.2.2 By Type - Global Oral Peptide Therapy Revenue, 2023-2028
  4.2.3 By Type - Global Oral Peptide Therapy Revenue Market Share, 2017-2028
4.3 By Type - Global Oral Peptide Therapy Sales & Forecasts
  4.3.1 By Type - Global Oral Peptide Therapy Sales, 2017-2022
  4.3.2 By Type - Global Oral Peptide Therapy Sales, 2023-2028
  4.3.3 By Type - Global Oral Peptide Therapy Sales Market Share, 2017-2028
4.4 By Type - Global Oral Peptide Therapy Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Oral Peptide Therapy Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Retail Pharmacy
5.2 By Application - Global Oral Peptide Therapy Revenue & Forecasts
  5.2.1 By Application - Global Oral Peptide Therapy Revenue, 2017-2022
  5.2.2 By Application - Global Oral Peptide Therapy Revenue, 2023-2028
  5.2.3 By Application - Global Oral Peptide Therapy Revenue Market Share, 2017-2028
5.3 By Application - Global Oral Peptide Therapy Sales & Forecasts
  5.3.1 By Application - Global Oral Peptide Therapy Sales, 2017-2022
  5.3.2 By Application - Global Oral Peptide Therapy Sales, 2023-2028
  5.3.3 By Application - Global Oral Peptide Therapy Sales Market Share, 2017-2028
5.4 By Application - Global Oral Peptide Therapy Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Oral Peptide Therapy Market Size, 2021 & 2028
6.2 By Region - Global Oral Peptide Therapy Revenue & Forecasts
  6.2.1 By Region - Global Oral Peptide Therapy Revenue, 2017-2022
  6.2.2 By Region - Global Oral Peptide Therapy Revenue, 2023-2028
  6.2.3 By Region - Global Oral Peptide Therapy Revenue Market Share, 2017-2028
6.3 By Region - Global Oral Peptide Therapy Sales & Forecasts
  6.3.1 By Region - Global Oral Peptide Therapy Sales, 2017-2022
  6.3.2 By Region - Global Oral Peptide Therapy Sales, 2023-2028
  6.3.3 By Region - Global Oral Peptide Therapy Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Oral Peptide Therapy Revenue, 2017-2028
  6.4.2 By Country - North America Oral Peptide Therapy Sales, 2017-2028
  6.4.3 US Oral Peptide Therapy Market Size, 2017-2028
  6.4.4 Canada Oral Peptide Therapy Market Size, 2017-2028
  6.4.5 Mexico Oral Peptide Therapy Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Oral Peptide Therapy Revenue, 2017-2028
  6.5.2 By Country - Europe Oral Peptide Therapy Sales, 2017-2028
  6.5.3 Germany Oral Peptide Therapy Market Size, 2017-2028
  6.5.4 France Oral Peptide Therapy Market Size, 2017-2028
  6.5.5 U.K. Oral Peptide Therapy Market Size, 2017-2028
  6.5.6 Italy Oral Peptide Therapy Market Size, 2017-2028
  6.5.7 Russia Oral Peptide Therapy Market Size, 2017-2028
  6.5.8 Nordic Countries Oral Peptide Therapy Market Size, 2017-2028
  6.5.9 Benelux Oral Peptide Therapy Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Oral Peptide Therapy Revenue, 2017-2028
  6.6.2 By Region - Asia Oral Peptide Therapy Sales, 2017-2028
  6.6.3 China Oral Peptide Therapy Market Size, 2017-2028
  6.6.4 Japan Oral Peptide Therapy Market Size, 2017-2028
  6.6.5 South Korea Oral Peptide Therapy Market Size, 2017-2028
  6.6.6 Southeast Asia Oral Peptide Therapy Market Size, 2017-2028
  6.6.7 India Oral Peptide Therapy Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Oral Peptide Therapy Revenue, 2017-2028
  6.7.2 By Country - South America Oral Peptide Therapy Sales, 2017-2028
  6.7.3 Brazil Oral Peptide Therapy Market Size, 2017-2028
  6.7.4 Argentina Oral Peptide Therapy Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Oral Peptide Therapy Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Oral Peptide Therapy Sales, 2017-2028
  6.8.3 Turkey Oral Peptide Therapy Market Size, 2017-2028
  6.8.4 Israel Oral Peptide Therapy Market Size, 2017-2028
  6.8.5 Saudi Arabia Oral Peptide Therapy Market Size, 2017-2028
  6.8.6 UAE Oral Peptide Therapy Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Allergan
  7.1.1 Allergan Corporate Summary
  7.1.2 Allergan Business Overview
  7.1.3 Allergan Oral Peptide Therapy Major Product Offerings
  7.1.4 Allergan Oral Peptide Therapy Sales and Revenue in Global (2017-2022)
  7.1.5 Allergan Key News
7.2 Novo Nordisk
  7.2.1 Novo Nordisk Corporate Summary
  7.2.2 Novo Nordisk Business Overview
  7.2.3 Novo Nordisk Oral Peptide Therapy Major Product Offerings
  7.2.4 Novo Nordisk Oral Peptide Therapy Sales and Revenue in Global (2017-2022)
  7.2.5 Novo Nordisk Key News
7.3 Synergy Pharmaceuticals ?Salix?
  7.3.1 Synergy Pharmaceuticals ?Salix? Corporate Summary
  7.3.2 Synergy Pharmaceuticals ?Salix? Business Overview
  7.3.3 Synergy Pharmaceuticals ?Salix? Oral Peptide Therapy Major Product Offerings
  7.3.4 Synergy Pharmaceuticals ?Salix? Oral Peptide Therapy Sales and Revenue in Global (2017-2022)
  7.3.5 Synergy Pharmaceuticals ?Salix? Key News
7.4 Novartis
  7.4.1 Novartis Corporate Summary
  7.4.2 Novartis Business Overview
  7.4.3 Novartis Oral Peptide Therapy Major Product Offerings
  7.4.4 Novartis Oral Peptide Therapy Sales and Revenue in Global (2017-2022)
  7.4.5 Novartis Key News
7.5 Chiasma
  7.5.1 Chiasma Corporate Summary
  7.5.2 Chiasma Business Overview
  7.5.3 Chiasma Oral Peptide Therapy Major Product Offerings
  7.5.4 Chiasma Oral Peptide Therapy Sales and Revenue in Global (2017-2022)
  7.5.5 Chiasma Key News

8 GLOBAL ORAL PEPTIDE THERAPY PRODUCTION CAPACITY, ANALYSIS

8.1 Global Oral Peptide Therapy Production Capacity, 2017-2028
8.2 Oral Peptide Therapy Production Capacity of Key Manufacturers in Global Market
8.3 Global Oral Peptide Therapy Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 ORAL PEPTIDE THERAPY SUPPLY CHAIN ANALYSIS

10.1 Oral Peptide Therapy Industry Value Chain
10.2 Oral Peptide Therapy Upstream Market
10.3 Oral Peptide Therapy Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Oral Peptide Therapy Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Oral Peptide Therapy in Global Market
Table 2. Top Oral Peptide Therapy Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Oral Peptide Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Oral Peptide Therapy Revenue Share by Companies, 2017-2022
Table 5. Global Oral Peptide Therapy Sales by Companies, (Units), 2017-2022
Table 6. Global Oral Peptide Therapy Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Oral Peptide Therapy Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Oral Peptide Therapy Product Type
Table 9. List of Global Tier 1 Oral Peptide Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oral Peptide Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Oral Peptide Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Oral Peptide Therapy Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Oral Peptide Therapy Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Oral Peptide Therapy Sales (Units), 2017-2022
Table 15. By Type - Global Oral Peptide Therapy Sales (Units), 2023-2028
Table 16. By Application – Global Oral Peptide Therapy Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Oral Peptide Therapy Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Oral Peptide Therapy Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Oral Peptide Therapy Sales (Units), 2017-2022
Table 20. By Application - Global Oral Peptide Therapy Sales (Units), 2023-2028
Table 21. By Region – Global Oral Peptide Therapy Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Oral Peptide Therapy Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Oral Peptide Therapy Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Oral Peptide Therapy Sales (Units), 2017-2022
Table 25. By Region - Global Oral Peptide Therapy Sales (Units), 2023-2028
Table 26. By Country - North America Oral Peptide Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Oral Peptide Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Oral Peptide Therapy Sales, (Units), 2017-2022
Table 29. By Country - North America Oral Peptide Therapy Sales, (Units), 2023-2028
Table 30. By Country - Europe Oral Peptide Therapy Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Oral Peptide Therapy Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Oral Peptide Therapy Sales, (Units), 2017-2022
Table 33. By Country - Europe Oral Peptide Therapy Sales, (Units), 2023-2028
Table 34. By Region - Asia Oral Peptide Therapy Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Oral Peptide Therapy Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Oral Peptide Therapy Sales, (Units), 2017-2022
Table 37. By Region - Asia Oral Peptide Therapy Sales, (Units), 2023-2028
Table 38. By Country - South America Oral Peptide Therapy Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Oral Peptide Therapy Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Oral Peptide Therapy Sales, (Units), 2017-2022
Table 41. By Country - South America Oral Peptide Therapy Sales, (Units), 2023-2028
Table 42. By Country - Middle East & Africa Oral Peptide Therapy Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Oral Peptide Therapy Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Oral Peptide Therapy Sales, (Units), 2017-2022
Table 45. By Country - Middle East & Africa Oral Peptide Therapy Sales, (Units), 2023-2028
Table 46. Allergan Corporate Summary
Table 47. Allergan Oral Peptide Therapy Product Offerings
Table 48. Allergan Oral Peptide Therapy Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Novo Nordisk Corporate Summary
Table 50. Novo Nordisk Oral Peptide Therapy Product Offerings
Table 51. Novo Nordisk Oral Peptide Therapy Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Synergy Pharmaceuticals ?Salix? Corporate Summary
Table 53. Synergy Pharmaceuticals ?Salix? Oral Peptide Therapy Product Offerings
Table 54. Synergy Pharmaceuticals ?Salix? Oral Peptide Therapy Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Novartis Corporate Summary
Table 56. Novartis Oral Peptide Therapy Product Offerings
Table 57. Novartis Oral Peptide Therapy Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Chiasma Corporate Summary
Table 59. Chiasma Oral Peptide Therapy Product Offerings
Table 60. Chiasma Oral Peptide Therapy Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Oral Peptide Therapy Production Capacity (Units) of Key Manufacturers in Global Market, 2020-2022 (Units)
Table 62. Global Oral Peptide Therapy Capacity Market Share of Key Manufacturers, 2020-2022
Table 63. Global Oral Peptide Therapy Production by Region, 2017-2022 (Units)
Table 64. Global Oral Peptide Therapy Production by Region, 2023-2028 (Units)
Table 65. Oral Peptide Therapy Market Opportunities & Trends in Global Market
Table 66. Oral Peptide Therapy Market Drivers in Global Market
Table 67. Oral Peptide Therapy Market Restraints in Global Market
Table 68. Oral Peptide Therapy Raw Materials
Table 69. Oral Peptide Therapy Raw Materials Suppliers in Global Market
Table 70. Typical Oral Peptide Therapy Downstream
Table 71. Oral Peptide Therapy Downstream Clients in Global Market
Table 72. Oral Peptide Therapy Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Oral Peptide Therapy Segment by Type
Figure 2. Oral Peptide Therapy Segment by Application
Figure 3. Global Oral Peptide Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Oral Peptide Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Oral Peptide Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. Oral Peptide Therapy Sales in Global Market: 2017-2028 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Oral Peptide Therapy Revenue in 2021
Figure 9. By Type - Global Oral Peptide Therapy Sales Market Share, 2017-2028
Figure 10. By Type - Global Oral Peptide Therapy Revenue Market Share, 2017-2028
Figure 11. By Type - Global Oral Peptide Therapy Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Oral Peptide Therapy Sales Market Share, 2017-2028
Figure 13. By Application - Global Oral Peptide Therapy Revenue Market Share, 2017-2028
Figure 14. By Application - Global Oral Peptide Therapy Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Oral Peptide Therapy Sales Market Share, 2017-2028
Figure 16. By Region - Global Oral Peptide Therapy Revenue Market Share, 2017-2028
Figure 17. By Country - North America Oral Peptide Therapy Revenue Market Share, 2017-2028
Figure 18. By Country - North America Oral Peptide Therapy Sales Market Share, 2017-2028
Figure 19. US Oral Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Oral Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Oral Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Oral Peptide Therapy Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Oral Peptide Therapy Sales Market Share, 2017-2028
Figure 24. Germany Oral Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. France Oral Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Oral Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Oral Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Oral Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Oral Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Oral Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Oral Peptide Therapy Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Oral Peptide Therapy Sales Market Share, 2017-2028
Figure 33. China Oral Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Oral Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Oral Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Oral Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. India Oral Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Oral Peptide Therapy Revenue Market Share, 2017-2028
Figure 39. By Country - South America Oral Peptide Therapy Sales Market Share, 2017-2028
Figure 40. Brazil Oral Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Oral Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Oral Peptide Therapy Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Oral Peptide Therapy Sales Market Share, 2017-2028
Figure 44. Turkey Oral Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Oral Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Oral Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Oral Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 48. Global Oral Peptide Therapy Production Capacity (Units), 2017-2028
Figure 49. The Percentage of Production Oral Peptide Therapy by Region, 2021 VS 2028
Figure 50. Oral Peptide Therapy Industry Value Chain
Figure 51. Marketing Channels